Search

Your search keyword '"Jung, Wonkyung"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Jung, Wonkyung" Remove constraint Author: "Jung, Wonkyung"
125 results on '"Jung, Wonkyung"'

Search Results

1. Generalizing AI-driven Assessment of Immunohistochemistry across Immunostains and Cancer Types: A Universal Immunohistochemistry Analyzer

2. Toward Practical Privacy-Preserving Convolutional Neural Networks Exploiting Fully Homomorphic Encryption

3. Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 cases

4. OCELOT: Overlapped Cell on Tissue Dataset for Histopathology

5. AESPA: Accuracy Preserving Low-degree Polynomial Activation for Fast Private Inference

7. BTS: An Accelerator for Bootstrappable Fully Homomorphic Encryption

9. Accelerating Number Theoretic Transformations for Bootstrappable Homomorphic Encryption on GPUs

10. HEAAN Demystified: Accelerating Fully Homomorphic Encryption Through Architecture-centric Analysis and Optimization

11. Identification of HER2 ultra-low based on an artificial intelligence (AI)-powered HER2 subcellular quantification from HER2 immunohistochemistry images.

12. Clinical Validation of Artificial Intelligence–Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non–Small Cell Lung Cancer

13. Restructuring Batch Normalization to Accelerate CNN Training

14. An artificial intelligence‐powered PD‐L1 combined positive score (CPS) analyser in urothelial carcinoma alleviating interobserver and intersite variability.

15. Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types

16. Generalizing AI-Driven Assessment of Immunohistochemistry Across Immunostains and Cancer Types: A Universal Mmunohistochemistry Analyzer

20. OCELOT: Overlapped Cell on Tissue Dataset for Histopathology

21. Kidney Donor Perspectives on Acute Postoperative Pain Management.

24. Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms

25. Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response

26. Abstract 6172: Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes reveals immune-excluded phenotype is correlated with TGF-beta pathway related genomic aberrations

27. BTS

29. Artificial intelligence (AI)–powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of response to neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC).

30. Artificial intelligence-powered human epidermal growth factor receptor 2 (HER2) analyzer in breast cancer as an assistance tool for pathologists to reduce interobserver variation.

31. Artificial intelligence-powered whole-slide image analyzer reveals a distinctive distribution of tumor-infiltrating lymphocytes in neuroendocrine tumors and carcinomas.

32. Observer performance study to examine the feasibility of the AI-powered PD-L1 analyzer to assist pathologists’ assessment of PD-L1 expression using tumor proportion score in non–small cell lung cancer.

33. Abstract P4-05-07: Assistance with an artificial intelligence-powered tumor infiltrating lymphocytes (TIL) analyzer reduces interobserver variation in pathologic scoring of TIL in breast cancer

36. 830 Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes reveals immune-excluded phenotype related to APOBEC signature and clonal evolution of cancer

40. Clinical performance of artificial intelligence-powered annotation of tumor cell PD-L1 expression for treatment of immune-checkpoint inhibitor (ICI) in advanced non-small cell lung cancer (NSCLC).

41. Artificial intelligence-powered spatial analysis of tumor infiltrating lymphocytes (TIL) to reflect target gene expressions of novel immuno-oncology agents.

42. Pathologic validation of artificial intelligence-powered prediction of combined positive score of PD-L1 immunohistochemistry in urothelial carcinoma.

49. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma

Catalog

Books, media, physical & digital resources